TET2 and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, high level of TET2‐mediated 5hmC in a subset of CGI/promoters with bivalent chromatin in healthy CD34+ cells could protect them against aberrant methylation in CP‐CML cells.